DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Truvada (Emtricitabine / Tenofovir Disoproxil Fumarate) - Current Clinical Trials

 


Nutrilib.com
A comprihensive source of nutritional information

Truvada Related Clinical Trials

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study [Completed]

Combination of Efavirenz and Truvada - COMET Study [Completed]

FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women [Not yet recruiting]

Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients [Not yet recruiting]

TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada [Active, not recruiting]

RECOMB: Peripheral Body Fat Distribution After Switching From AZT Containing Backbone to Truvada [Active, not recruiting]

Truvada Versus Truvada Plus HBIG in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant [Recruiting]

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection [Active, not recruiting]

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial [Recruiting]

GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance [Active, not recruiting]

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment [Recruiting]

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada [Active, not recruiting]

Observational Non-Interventional Study With Viramune in Combination With Truvada in HIV-Infected Patients [Recruiting]

Backup With Combivir or Single Dose (Sd) Truvada in Order to Avoid NNRTI Resistance After Sd Nevirapine for the PMTCT [Recruiting]

A Study to Evaluate the Safety and Antiretroviral Activity of MK0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA(TM) [Active, not recruiting]

Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men [Recruiting]

Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals [Recruiting]

Standard Antiretroviral Versus Multi-Class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01) [Recruiting]

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in HIV Infected Naive Patients (NEwArT) [Recruiting]

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV [Active, not recruiting]

SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada [Completed]

A 72-Week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP [Recruiting]

The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection [Not yet recruiting]

A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir [Recruiting]

Efficacy and Tolerance of Peg-Interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV co-Infected Patients [Recruiting]

Safety and Efficacy Study of Switching From Epzicom to Truvada [Recruiting]

ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens [Not yet recruiting]

Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA) [Recruiting]

Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection [Not yet recruiting]

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects [Completed]

Anti-Retrovirals for Kaposi’s Sarcoma [Not yet recruiting]

Intensification With Enfuvirtide in Naive HIV-Infected Patients [Recruiting]

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults [Active, not recruiting]

Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease. [Active, not recruiting]

Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875AM2) [Recruiting]

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada [Recruiting]

Raltegravir as Early Therapy in African-Americans Living With HIV Study [Recruiting]

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg [Recruiting]

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment [Recruiting]

Bone Mineral Density Substudy - An Ancillary Study to MTN-003 [Not yet recruiting]

Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women [Not yet recruiting]

Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples [Recruiting]

Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection [Recruiting]

Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants [Active, not recruiting]

Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy [Recruiting]

HIV Non Occupational Post-Exposure Prophylaxis (PEP) [Recruiting]

Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients [Completed]

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects [Withdrawn]

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir DF in HIV-1-Infected Treatment Naive Adults [Active, not recruiting]

Preventing Sexual Transmission of HIV With Anti-HIV Drugs [Recruiting]

HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV [Recruiting]

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults [Not yet recruiting]

Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients [Not yet recruiting]

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects [Recruiting]

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) [Recruiting]

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-Based HAART in Advanced HIV Disease [Recruiting]

Tenofovir Disoproxil Fumarate (DF) Versus Emtricitabine/Tenofovir DF Fixed-Dose in Subjects Resistant to Lamivudine [Recruiting]

Phase IIB Pilot of Atazanavir + Raltegravir [Not yet recruiting]

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections [Active, not recruiting]

NNRTI Versus PI Containing Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child Transmission of HIV [Recruiting]

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV [Recruiting]

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV Infected Adults Being Treated for Tuberculosis [Recruiting]

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy [Recruiting]

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection [Recruiting]

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV [Recruiting]

FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment [Completed]

A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes, and Eliminates a Drug), of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Nave HIV-1 Patients (Patients Have Never Received ARV Treatment). [Active, not recruiting]

Anti-HIV Medications for the Prevention of HIV Infection in Latin American Men Who Have Sex With Men [Not yet recruiting]

Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-Infected Patients That Have Never Received Treatment. [Not yet recruiting]

A 96 Week Study to Compare Tenofovir Versus Tenofovir Plus Emtricitabine for the Treatment of Chronic Hepatitis B [Active, not recruiting]

PREventing Progression of Adipose Tissue Redistribution [Recruiting]

A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine [Active, not recruiting]

ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial [Recruiting]

Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism [Recruiting]

ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla [Recruiting]

Second-Line Therapy AntiRetroviral in Patients Who Failed NNRTI-Based Regimens [Not yet recruiting]

Clinical Trial of CNS-Targeted HAART (CIT2) [Recruiting]

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008